| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.22 | 2e-05 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.14 | 8e-05 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.21 | 0.0002 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |